抗抑郁药治疗社交焦虑障碍的临床研究  

Clinical study of antidepressants in the treatment of social anxiety disorder

作　　者：何磊英[1] 陆峥[1] 

机构地区：[1]同济大学附属同济医院精神医学科,上海200065

出　　处：《世界临床药物》2009年第7期431-436,共6页World Clinical Drug

摘　　要：社交焦虑障碍(SAD)是一种常见的、能导致社会功能受损的疾病,是继重度抑郁发作、酒精依赖后的第三大常见精神障碍。患者社交功能、职业功能和日常生活等均可因此受到严重影响。本文就近年抗抑郁药治疗SAD的研究进展进行综述。Social anxiety disorder （SAD） is a common disease, which can lead to impaired social function. It is the third most common mental disorders. Social function, professional features and aspects of daily life of patients can be affected seriously. This article reviews the development of antidepressants in the treatment of social anxiety disorder in recent years.

关 键 词：社交焦虑障碍 选择性5-羟色胺再摄取抑制剂 可逆性单胺氧化酶抑制剂 5-羟色胺和去甲肾上腺素再摄取抑 制剂 

分 类 号：R749.72[医药卫生—神经病学与精神病学]